STOK — Stoke Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Stoke Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	222	287	220	230	201
Net Total Receivables	0.281	0.006	0.132	0.588	0.064
Prepaid Expenses
Total Other Current Assets
Total Current Assets	226	294	229	244	215
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.51	3.79	9.08	11.4	12.4
Other Long Term Assets
Total Assets	229	298	239	256	228
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	4.1	11.4	17.1	31.4	30.8
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	4.32	11.8	21.1	71.2	68.8
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	224	286	218	185	160
Total Liabilities & Shareholders' Equity	229	298	239	256	228
Total Common Shares Outstanding